期刊
MOLECULAR AND CELLULAR ENDOCRINOLOGY
卷 379, 期 1-2, 页码 2-11出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.mce.2013.06.004
关键词
Mitochondrial disease; Endocrine; mtDNA; Diabetes; m.3243A > G
资金
- Wellcome Trust [096919/Z/11/Z]
- UK NHS
- MRC [MR/K000608/1, G0700718] Funding Source: UKRI
- Medical Research Council [G0700718, MR/K000608/1] Funding Source: researchfish
Endocrine dysfunction in mitochondrial disease is commonplace, but predominantly restricted to disease of the endocrine pancreas resulting in diabetes mellitus. Other endocrine manifestations occur, but are relatively rare by comparison. In mitochondrial disease, neuromuscular symptoms often dominate the clinical phenotype, but it is of paramount importance to appreciate the multi-system nature of the disease, of which endocrine dysfunction may be a part. The numerous phenotypes attributable to pathogenic mutations in both the mitochondrial (mtDNA) and nuclear DNA creates a complex and heterogeneous catalogue of disease which can be difficult to navigate for novices and experts alike. In this article we provide an overview of the endocrine disorders associated with mitochondrial disease, the way in which the underlying mitochondrial disorder influences the clinical presentation, and how these factors influence subsequent management. (C) 2013 The Authors. Published by Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据